In the ever-evolving landscape of the biotech industry, resilience and adaptability are paramount for startups seeking long-term success. Join us for an enlightening panel discussion where we delve into the heart of biotech innovation and the strategies that shape its trajectory.

This event promises a deep dive into the strategic intricacies that biotech entrepreneurs face during economic adversities. With a focus on funding during downturns, effective commercialization strategies, and safeguarding innovations through robust intellectual property (IP) protection, attendees will emerge equipped with a comprehensive toolkit to steer their startups to success.

Key Discussion Points:

1. Funding: Navigating the Financial Frontier

Discover the art of attracting and retaining funding as you embark on the startup journey.

2. Commercialization Strategy: Paving the Road to Market

Explore the critical path to commercialization and why laying this foundation early is crucial.

3. Legal Strategy: Protecting Your Innovation

Understand the importance of a robust intellectual property strategy in safeguarding your innovations and maintaining a competitive advantage.

Meet Our Panelists:

Katherine Rubino: Partner & Chair, Life Sciences Practice Group, CALDWELL

Christine Cole: Head of Philanthropy and Partnerships, The Termeer Foundation

Christina Ansted: Founder & CEO, Rapid Commercialization Partners

Kristen Park Hopson: VP of Preclinical Discovery and Development, Generate Biomedicines, Inc.

Moderated by: Jinane Abounadi: Executive Director, MIT Sandbox Innovation Fund

Challenges and Opportunities for Biotech Innovation: Scaling for Success